Dosing chart / Growth hormone

CJC-1295 (no DAC) dosage

Also known as: Mod GRF 1-29

What is CJC-1295 (no DAC)?

CJC-1295 without DAC, often sold as Mod GRF 1-29, is a synthetic 29-amino-acid peptide modeled on the active end of growth hormone-releasing hormone (GHRH), the brain signal that tells the pituitary gland to release growth hormone. It carries four amino acid changes meant to slow its breakdown. It is a different molecule from CJC-1295 with DAC: it lacks the drug affinity complex, the add-on that lets the DAC version attach to the blood protein albumin and last for days.

How it works

It is proposed to act like natural GHRH, binding receptors on the pituitary gland and prompting a release of the body's own growth hormone. This is inferred from its structure and from related peptides such as sermorelin, not from human studies of this molecule.

What the evidence shows

There are no completed human efficacy trials of this peptide. A 2026 peer-reviewed review of growth hormone peptides found no peer-reviewed human studies of CJC-1295 without DAC and placed it in its lowest evidence tier, noting that claims about growth hormone pulses and body composition are borrowed from sermorelin research and non-academic sources. Its half-life in humans has not been reported. The published human studies of CJC-1295 used the DAC version, so their results cannot be assumed to apply here.

Reported side effects

  • No human safety data from peer-reviewed studies of this specific peptide
  • Increased heart rate and a body-wide flushing (vasodilatory) reaction, listed by the FDA as serious adverse events associated with CJC-1295
  • Effects reported for growth hormone-stimulating peptides as a group: fluid retention, joint and muscle pain, blood sugar changes and injection-site reactions

Cautions

  • The FDA lists CJC-1295 among bulk substances that may present significant safety risks when compounded, citing immune reaction risk, peptide impurities and limited clinical data.
  • Products sold as research compounds have uncertain purity, dose consistency and sterility.
  • Published papers use the name CJC-1295 for both the DAC and the non-DAC peptide, so the name alone does not show which one is meant.
  • Competitive athletes risk a multi-year ban; US anti-doping authorities treat CJC-1295 as prohibited at all times.

Legal and regulatory status

CJC-1295 without DAC is not an FDA-approved drug, and the FDA includes CJC-1295 on its list of bulk substances that may present significant safety risks in compounding. GHRH and its synthetic analogs are prohibited by WADA, and USADA lists CJC-1295 as prohibited at all times.

Common questions

What is the difference between CJC-1295 with DAC and without DAC?

Both are modified 29-amino-acid GHRH fragments. The DAC version has an extra chemical group that binds it to albumin in the blood, giving it a half-life of roughly a week in human studies. The version without DAC lacks that group, and its half-life in humans has not been reported.

Is Mod GRF 1-29 the same as CJC-1295?

Mod GRF 1-29 is another name for CJC-1295 without DAC. Published papers use the plain name CJC-1295 for both the DAC and the non-DAC peptide, so the name alone does not reliably tell you which one is meant.

Has CJC-1295 without DAC been tested in people?

A 2026 peer-reviewed review found no peer-reviewed human studies of it. The published human trials of CJC-1295 used the long-acting DAC version and measured hormone levels only.

Sources

  1. Frontiers in Endocrinology (2026): Performance-enhancing peptides modulating the GH-IGF1 axis
  2. FDA: Certain bulk drug substances for use in compounding that may present significant safety risks
  3. Endocrinology (2005), PubMed record 15817669: hGRF(1-29)-albumin bioconjugates and identification of CJC-1295
  4. Drug Testing and Analysis (2021), PubMed record 34665524: Detection of GHRH synthetic analogs
  5. Journal of Clinical Endocrinology and Metabolism (2006): CJC-1295 in healthy adults
  6. USADA: Anthony McCauley accepts doping sanction

CJC-1295 (no DAC) reviews and Q&A

TopicRepliesLast activity

No reviews or questions yet. Be the first.

More in Growth hormone

Stacks that include CJC-1295 (no DAC)

Compare CJC-1295 (no DAC)

Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.